Hematopoietic Stem Cell Transplantation (HSCT) Market to reach US$ 37,612.4 Million in 2025

Hematopoietic stem cells are young or immature blood cells found to be living in bone marrow. These blood cells on mature in bone marrow and only a small number of these cells get to enter blood stream. These cells that enter blood stream are called as peripheral blood stems cells. Hematopoietic stem cells transplantation is replacement of absent, diseased or damaged hematopoietic stem cells due to chemotherapy or radiation, with healthy hematopoietic stem cells. Over last 30 years hematopoietic stem cells transplantation market seen rapid expansion and constant expansion with lifesaving technological advances. Hematopoietic stem cells transplantation is also known blood and marrow transplantation which brings about reestablishment of the patient’s immune and medullary function while treating varied range of about 70 hematological and non-hematological disorders. In general hematopoietic stem cells transplantation is used in treatment of hereditary, oncological, immunological and malignant and non-malignant hematological diseases.

Browse Report with Complete TOC - http://www.transparencymarketresearch.com/hematopoietic-stem-cell-transplantation-market.html

Geographically, the hematopoietic stem cell transplantation (HSCT) is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Europe and North America were recorded with significant market share in the HSCT market, owing to large population size, growing disease prevalence and increase in health expenditure has boosted hematopoietic stem cell transplantation (HSCT) in the region. Europe holds a dominant position owing to the prevalence of hematological disorders and non-hematological disorders has shown a dramatic increase in the region. According to European Brain Council, around 1.2 million people are suffering from Parkinson’s disease; and according to the Journal of Rehabilitation Research and Development, around 350,000 people are suffering from multiple sclerosis in Europe. Moreover, over 500,000 people have leukemia according to Cancer Research, U.K. Furthermore, according to W.H.O., more than half of the deaths in Europe are due to heart disease, signifying the urgency and the need for treatment of these diseases in the region. In addition, most of the countries in Western Europe have high per capita income, according to IMF statistics. This indicates the clear affordability of stem cell treatment by the European population, which might cost over USD 1 million, thus garnering the Europe is the 2nd largest market.

North America is the 2nd largest market for North America owing to the well-established hematopoietic stem cells transplantation (HSCT) market in the U.S. U.S holds the maximum share of North America hematopoietic stem cells transplantation (HSCT) and is expected to hold the dominant position over the forecast period owing to the presence of strong research and healthcare capital, introduction of improved and technologically advanced hematopoietic stem cells transplantation services and high gross domestic product (GDP) of the country. About 20,000 hematopoietic stem cells transplantations are carried out in U.S alone.
Hematopoietic stem cells transplantation (HSCT) market in Asia Pacific is expected to witness the rapid growth rate from 2017 to 2025. Japan accounted for the maximum share of this market in 2015. After Japan in Asia-Pacific region China and India is estimated to grow at the decent rate owing to rapid adoption hematopoietic stem cells transplantations for treatment of cancer, leukemia, and other blood disorders. In APAC region the market is share is completely due to the low cost of hematopoietic stem cells transplantation as compared to Europe and North America. Brazil is a key market in Latin America. Mexico and Brazil are undoubtedly the largest markets in the region. Improving health care scenario, rise in participation of population and favorable government initiatives are the major factors fueling the growth of hematopoietic stem cells transplantation (HSCT) market in Latin America.

Middle East & Africa (MEA) also expected to contribute averagely to the global hematopoietic stem cells transplantation (HSCT) market in the near future. In the Middle East and Africa, increasing participation of research institutes, and government initiatives to support clinical trials for stem cells transplantation therapy is expected to drive the market in this region. On June 03, 2016, the U.S. and Kingdom of Saudi Arabia announced establishment of an international consortium to promote research & development (R&D) in clinical research.

Inquire for a Sample Copy of Report - http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=23861

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.